Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 3
2005 7
2006 5
2007 5
2008 4
2009 4
2010 6
2011 9
2012 7
2013 8
2014 5
2015 7
2016 7
2017 8
2018 9
2019 13
2020 7
2021 13
2022 7
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Emotion regulation from a virtue perspective.
Kim JH, Chun J, Kim J, Ju HJ, Kim BJ, Jeong J, Lee DH. Kim JH, et al. Among authors: kim bj. BMC Psychol. 2024 Jan 3;12(1):11. doi: 10.1186/s40359-023-01490-y. BMC Psychol. 2024. PMID: 38173038 Free PMC article.
Effectiveness of low-intensity atorvastatin 5 mg and ezetimibe 10 mg combination therapy compared with moderate-intensity atorvastatin 10 mg monotherapy: A randomized, double-blinded, multi-center, phase III study.
Lee SA, Hong SJ, Sung JH, Kim KS, Kim SH, Cho JM, Chun SW, Lee SR, Kim CS, Kim TN, Kim DH, Park HC, Kim BJ, Kim HS, Choi JY, Hong YJ, Chung JW, Yoon SB, Lee SH, Lee CW. Lee SA, et al. Among authors: kim bj. Medicine (Baltimore). 2023 Nov 24;102(47):e36122. doi: 10.1097/MD.0000000000036122. Medicine (Baltimore). 2023. PMID: 38013289 Free PMC article. Clinical Trial.
Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial.
Kim BJ, Cha KS, Cho WH, Kim EJ, Choi SH, Kim MH, Kim SH, Park JB, Park SM, Sohn IS, Ryu KH, Chae IH. Kim BJ, et al. J Cardiovasc Pharmacol Ther. 2023 Jan-Dec;28:10742484231205204. doi: 10.1177/10742484231205204. J Cardiovasc Pharmacol Ther. 2023. PMID: 37814541 Free article. Clinical Trial.
129 results